Plant-Based
Pure Extracts signs tolling agreement for 500 kgs of CBD rich hemp
VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp,…

VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, reported that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp., has signed a tolling agreement for the extraction of 80-85% pure CBD distillate from an initial 500 kgs of hemp biomass.
The biomass was sourced from one of Pure Extracts’ preferred suppliers and has a CBD potency of just over 10%. This biomass, with its specific particulate mill size, runs very efficiently on the Company’s Vitalis R200 sub/super-critical CO2 extraction system.
The high level of purity in the extracted CBD distillate makes it an ideal ingredient for vape cartridges, topicals, beverages and edible gummies and chocolates.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are pleased to have entered into this tolling agreement and to have taken delivery of the first 500 kg of milled hemp biomass. We are very familiar with this particular biomass having used it before in the manufacturing of our in-house, branded products, so we know it extracts very well.”
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
We seek Safe Harbor.
beverages plant-based cse otc